1
|
Santos PC, Santos DA, Ribeiro LS, Fagundes CT, de Paula TP, Avila TV, Baltazar LDM, Madeira MM, Cruz RDC, Dias ACF, Machado FS, Teixeira MM, Cisalpino PS, Souza DG. The pivotal role of 5-lipoxygenase-derived LTB4 in controlling pulmonary paracoccidioidomycosis. PLoS Negl Trop Dis 2013; 7:e2390. [PMID: 23991239 PMCID: PMC3749973 DOI: 10.1371/journal.pntd.0002390] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2013] [Accepted: 07/17/2013] [Indexed: 01/30/2023] Open
Abstract
Leukotrienes (LTs) produced from arachidonic acid by the action of 5-lipoxygenase (5-LO) are classical mediators of inflammatory responses. However, studies published in the literature regarding these mediators are contradictory and it remains uncertain whether these lipid mediators play a role in host defense against the fungal pathogen Paracoccidioides brasiliensis. To determine the involvement of LTs in the host response to pulmonary infection, wild-type and LT-deficient mice by targeted disruption of the 5-lipoxygenase gene (knockout mice) were studied following intratracheal challenge with P. brasiliensis yeasts. The results showed that infection is uniformly fatal in 5-LO-deficient mice and the mechanisms that account for this phenotype are an exacerbated lung injury and higher fungal pulmonary burden. Genetic ablation or pharmacological inhibition of LTs resulted in lower phagocytosis and fungicidal activity of macrophages in vitro, suggesting that deficiency in fungal clearance seems to be secondary to the absence of activation in 5-LO(-/-) macrophages. Exogenous LTB4 restored phagocytosis and fungicidal activity of 5-LO(-/-) macrophages. Moreover, P. brasiliensis killing promoted by LTB4 was dependent on nitric oxide (NO) production by macrophages. Taken together, these results reveal a fundamental role for 5-LO-derived LTB4 in the protective response to P. brasiliensis infection and identify relevant mechanisms for the control of fungal infection during the early stages of the host immune response.
Collapse
Affiliation(s)
- Patrícia Campi Santos
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Daniel Assis Santos
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Lucas Secchim Ribeiro
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Caio Tavares Fagundes
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Inflammation Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
| | - Talles Prosperi de Paula
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Thiago Vinícius Avila
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Ludmila de Matos Baltazar
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Mila Moreira Madeira
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Rosana de Carvalho Cruz
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Ana Carolina Fialho Dias
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Fabiana Simão Machado
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Mauro Martins Teixeira
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Patrícia Silva Cisalpino
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
| | - Danielle G. Souza
- Laboratory of Microorganism-Host Interaction, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- Laboratory of Immunopharmacology/Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, Brazil
- * E-mail:
| |
Collapse
|
2
|
Gobbetti T, Cenac N, Motta JP, Rolland C, Martin L, Andrade-Gordon P, Steinhoff M, Barocelli E, Vergnolle N. Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine. THE AMERICAN JOURNAL OF PATHOLOGY 2011; 180:141-52. [PMID: 22067907 DOI: 10.1016/j.ajpath.2011.09.031] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2011] [Revised: 08/26/2011] [Accepted: 09/20/2011] [Indexed: 01/17/2023]
Abstract
Proteases and proteinase-activated receptor (PAR) activation are involved in several intestinal inflammatory conditions. We hypothesized that serine proteases and PAR activation could also modulate the intestinal injury induced by ischemia-reperfusion (I-R). C57Bl/6 mice were subjected to 90 minutes of intestinal ischemia followed or not by reperfusion. Sham-operated animals served as controls. After ischemia, plasma and tissue serine protease activity levels were increased compared to the activity measured in plasma and tissues from sham-operated mice. This increase was maintained or further enhanced after 2 and 5 hours of reperfusion, respectively. Trypsin (25 kDa) was detected in tissues both after ischemia and 2 hours of reperfusion. Treatment with FUT-175 (10 mg/kg), a potent serine protease inhibitor, increased survival after I-R, inhibited tissue protease activity, and significantly decreased intestinal myeloperoxidase (MPO) activity and chemokine and adhesion molecule expression. We investigated whether serine proteases modulate granulocyte recruitment by a PAR-dependent mechanism. MPO levels and adhesion molecule expression were significantly reduced in I-R groups pre-treated with the PAR(1) antagonist SCH-79797 (5 mg/kg) and in Par(2)(-/-)mice, compared, respectively, to vehicle-treated group and wild-type littermates. Thus, increased proteolytic activity and PAR activation play a pathogenic role in intestinal I-R injury. Inhibition of PAR-activating serine proteases could be beneficial to reduce post-ischemic intestinal inflammation.
Collapse
Affiliation(s)
- Thomas Gobbetti
- INSERM, U1043, UPS, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Zurier RB, Sun YP, George KL, Stebulis JA, Rossetti RG, Skulas A, Judge E, Serhan CN. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J 2009; 23:1503-9. [PMID: 19124557 DOI: 10.1096/fj.08-118323] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Ajulemic acid (AjA), a synthetic nonpsychoactive cannabinoid, and lipoxin A(4) (LXA(4)), an eicosanoid formed from sequential actions of 5- and 15-lipoxygenases (LOX), facilitate resolution of inflammation. The purpose of this study was to determine whether the ability of AjA to limit the progress of inflammation might relate to an increase in LXA(4), a known anti-inflammatory and proresolving mediator. Addition of AjA (0-30 microM) in vitro to human blood and synovial cells increased production of LXA(4) (ELISA) 2- to 5-fold. Administration of AjA to mice with peritonitis resulted in a 25-75% reduction of cells invading the peritoneum, and a 7-fold increase in LXA(4) identified by mass spectrometry. Blockade of 12/15 LOX, which leads to LXA(4) synthesis via 15-HETE production, reduced (>90%) the ability of AjA to enhance production of LXA(4) in vitro. These results suggest that AjA and other agents that increase endogenous compounds that facilitate resolution of inflammation may be useful for conditions characterized by inflammation and tissue injury.
Collapse
Affiliation(s)
- Robert B Zurier
- University of Massachusetts Medical School, Division of Rheumatology, 55 Lake Ave, Worcester, MA 01655, USA.
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Abstract
Heparin is a major anticoagulant with activity mediated primarily through its interaction with antithrombin (AT). Heparan sulfate (HS), structurally related to heparin, binds a wide range of proteins of different functionality, taking part in various physiological and pathological processes. The heparin-AT complex, the most well understood facet of anticoagulation, serves as a prototypical example of the important role of heparin/HS in vascular biology. Extensive studies have identified common structural features in heparin/HS-binding sites of proteins. These include the elucidation of consensus sequences in proteins, patterns of clusters of basic and nonbasic residues, and common spatial arrangements of basic amino acids in the heparin-binding sites. Although these studies have provided valuable information, heparin/HS-binding proteins differ widely in structure. The prediction of heparin/HS-binding proteins from sequence information is not currently possible, and elucidation of protein-binding sites requires the individual study of each glycosaminoglycan-protein complex. Thus, x-ray crystallography and site-directed mutagenesis experiments are among the most powerful tools, providing accurate structural information, facilitating the characterization of heparin-protein complexes. Heparin and structurally related heparan sulfate bind a large number of proteins, taking part in a wide range of biological processes, particularly ones involved in vascular biology. Heparin-binding domains share certain common structural features, but there is no absolute dependency on specific sequences or protein folds.
Collapse
Affiliation(s)
- Eva M Muñoz
- Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180, USA
| | | |
Collapse
|